Ethical Management of COVID-19 Pandemic at a Neurological Hospital: The Ethicovid Report.


Journal

Journal of neurosurgical anesthesiology
ISSN: 1537-1921
Titre abrégé: J Neurosurg Anesthesiol
Pays: United States
ID NLM: 8910749

Informations de publication

Date de publication:
01 Oct 2023
Historique:
received: 10 11 2021
accepted: 30 03 2022
medline: 13 9 2023
pubmed: 12 5 2022
entrez: 11 5 2022
Statut: ppublish

Résumé

During the first wave of the coronavirus disease-2019 (COVID-19) pandemic, it was necessary to prepare for the possibility of triaging patients who could benefit from access to an intensive care unit (ICU). In our neuroscience institution, the challenge was to continue to manage usual neurological emergencies as well as the influx of COVID-19 patients. We report the experience of an ethical consulting unit to support care clinical decisions during the first wave of the pandemic (March 16 to April 30, 2020). Three objective evaluation criteria were defined: 2 of these criteria, patient's factors and general disease severity (Simplified Acute Physiology Score II), were common to all patients, and the third was the specific severity of the disease (neurological for brain injury, respiratory for COVID-19). Given our scarce resources, we used a high probability of a 3-month modified Rankin Scale ≤3 as the criterion for further resuscitation and management. A total of 295 patients were admitted during the first pandemic wave; 111 with COVID-19 and 184 with neurological emergencies. The ethical unit's expertise was sought for 75 clinical situations in 56 patients (35 COVID-19 and 21 neurological). Decisions were as follows: 11% no limitation on care, 5% expectant care with reassessment (maximum therapy to assess possible progress pending decision), 67% partial limitation (no intensification of care or no transfer to ICU), and 17% limitation of curative care. At no time did a lack of availability of ICU beds require the ethical unit to advise against admission to the ICU. Our ethical consulting unit allowed for collegial ethical decision-making in line with international recommendations. This model could be easily transferred to other triage situations, provided it is adapted to the local context.

Sections du résumé

BACKGROUND BACKGROUND
During the first wave of the coronavirus disease-2019 (COVID-19) pandemic, it was necessary to prepare for the possibility of triaging patients who could benefit from access to an intensive care unit (ICU). In our neuroscience institution, the challenge was to continue to manage usual neurological emergencies as well as the influx of COVID-19 patients.
METHODS METHODS
We report the experience of an ethical consulting unit to support care clinical decisions during the first wave of the pandemic (March 16 to April 30, 2020). Three objective evaluation criteria were defined: 2 of these criteria, patient's factors and general disease severity (Simplified Acute Physiology Score II), were common to all patients, and the third was the specific severity of the disease (neurological for brain injury, respiratory for COVID-19). Given our scarce resources, we used a high probability of a 3-month modified Rankin Scale ≤3 as the criterion for further resuscitation and management.
RESULTS RESULTS
A total of 295 patients were admitted during the first pandemic wave; 111 with COVID-19 and 184 with neurological emergencies. The ethical unit's expertise was sought for 75 clinical situations in 56 patients (35 COVID-19 and 21 neurological). Decisions were as follows: 11% no limitation on care, 5% expectant care with reassessment (maximum therapy to assess possible progress pending decision), 67% partial limitation (no intensification of care or no transfer to ICU), and 17% limitation of curative care. At no time did a lack of availability of ICU beds require the ethical unit to advise against admission to the ICU.
CONCLUSIONS CONCLUSIONS
Our ethical consulting unit allowed for collegial ethical decision-making in line with international recommendations. This model could be easily transferred to other triage situations, provided it is adapted to the local context.

Identifiants

pubmed: 35543619
doi: 10.1097/ANA.0000000000000849
pii: 00008506-990000000-00011
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

417-422

Informations de copyright

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors have no conflicts of interest to declare.

Références

Emanuel EJ, Persad G, Upshur R, et al. Fair allocation of scarce medical resources in the time of COVID-19. N Engl J Med. 2020;382:2049–2055. doi:10.1056/NEJMsb2005114
doi: 10.1056/NEJMsb2005114
Azoulay E, Beloucif S, Guidet B, et al. Admission decisions to intensive care units in the context of the major COVID-19 outbreak: local guidance from the COVID-19 Paris-region area. Crit Care. 2020;24:293. doi:10.1186/s13054-020-03021-2
doi: 10.1186/s13054-020-03021-2
Joebges S, Biller-Andorno N. Ethics guidelines on COVID-19 triage—an emerging international consensus. Crit Care. 2020;24:201. doi:10.1186/s13054-020-02927-1
doi: 10.1186/s13054-020-02927-1
Daugherty Biddison EL, Faden R, Gwon HS, et al. Too many patients … a framework to guide statewide allocation of scarce mechanical ventilation during disasters. Chest. 2019;155:848–854. doi:10.1016/j.chest.2018.09.025
doi: 10.1016/j.chest.2018.09.025
Robert R, Kentish-Barnes N, Boyer A, et al. Ethical dilemmas due to the COVID-19 pandemic. Ann Intensive Care. 2020;10:84. doi:10.1186/s13613-020-00702-7
doi: 10.1186/s13613-020-00702-7
Maves RC, Downar J, Dichter JR, et al. Triage of scarce critical care resources in COVID-19: an implementation guide for regional allocation. Chest. 2020;158:212–225. doi:10.1016/j.chest.2020.03.063
doi: 10.1016/j.chest.2020.03.063
Jöbges S, Vinay R, Luyckx VA, et al. Recommendations on COVID‐19 triage: international comparison and ethical analysis. Bioethics. 2020;34:948–959. doi:10.1111/bioe.12805
doi: 10.1111/bioe.12805
Sprung CL, Joynt GM, Christian MD, et al. Adult ICU triage during the coronavirus disease 2019 pandemic: who will live and who will die? Recommendations to improve survival. Crit Care Med. 2020;48:1196–1202. doi:10.1097/CCM.0000000000004410
doi: 10.1097/CCM.0000000000004410
Rubin MA, Bonnie RJ, Epstein L, et al. AAN position statement: the COVID-19 pandemic and the ethical duties of the neurologist. Neurology. 2020;95:167–172. doi:10.1212/WNL.0000000000009744
doi: 10.1212/WNL.0000000000009744
Raith EP, Luoma AMV, Earl M, et al. Repurposing a neurocritical care unit for the management of severely ill patients with COVID-19: a retrospective evaluation. J Neurosurg Anesthesiol. 2021;33:77–81. doi:10.1097/ANA.0000000000000727
doi: 10.1097/ANA.0000000000000727
Thabet AM, Kottapally M, Hemphill JC. Management of intracerebral hemorrhage. Handb Clin Neurol. 2017;140:177–194. doi:10.1016/B978-0-444-63600-3.00011-8
doi: 10.1016/B978-0-444-63600-3.00011-8
Blot F, Dumont SN, Vigouret-Viant L, et al. Ethical issues related to the COVID-19 pandemic in patients with cancer: experience and organisations in a French comprehensive cancer centre. BMJ Support Palliat Care. 2020. doi:10.1136/bmjspcare-2020-002504
doi: 10.1136/bmjspcare-2020-002504
White DB, Lo B. Mitigating inequities and saving lives with ICU triage during the COVID-19 pandemic. Am J Respir Crit Care Med. 2021;203:287–295. doi:10.1164/rccm.202010-3809CP.
doi: 10.1164/rccm.202010-3809CP.
Gessler F, Lehmann F, Bösel J, et al. Triage and allocation of neurocritical care resources during the COVID 19 pandemic—a national survey. Front Neurol. 2021;11:609227. doi:10.3389/fneur.2020.609227
doi: 10.3389/fneur.2020.609227
Zivot J. Coronavirus disease 2019 triage teams: death by numbers. Crit Care Med. 2020;48:1241–1242. doi:10.1097/CCM.0000000000004435
doi: 10.1097/CCM.0000000000004435
Solomon MZ, Wynia MK, Gostin LO. Covid-19 crisis triage—optimizing health outcomes and disability rights. N Engl J Med. 2020;383:e27. doi:10.1056/NEJMp2008300
doi: 10.1056/NEJMp2008300
Ho EP, Neo H-Y. COVID 19: prioritise autonomy, beneficence and conversations before score-based triage. Age Ageing. 2021;50:11–15. doi:10.1093/ageing/afaa205
doi: 10.1093/ageing/afaa205
Guidet B, Leblanc G, Simon T, et al. Effect of systematic intensive care unit triage on long-term mortality among critically ill elderly patients in france: a randomized clinical trial. JAMA. 2017;318:1450–1459. doi:10.1001/jama.2017.13889
doi: 10.1001/jama.2017.13889
Hulsbergen AFC, Eijkholt MM, Balak N, et al. Ethical triage during the COVID-19 pandemic: a toolkit for neurosurgical resource allocation. Acta Neurochir (Wien). 2020;162:1485–1490. doi:10.1007/s00701-020-04375-w
doi: 10.1007/s00701-020-04375-w
COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study. Intensive Care Med. 2021;47:60–73. doi:10.1007/s00134-020-06294-x
doi: 10.1007/s00134-020-06294-x

Auteurs

Nicolas Engrand (N)

Intensive Care Unit-Anesthesiology/Mobile Palliative Care Team.

Thomas Sene (T)

Departments of Internal Medicine.

Georges Caputo (G)

Ophthalmology.

Charles Gregoire (C)

Intensive Care Unit-Anesthesiology/Mobile Palliative Care Team.

Raphael Blanc (R)

Interventional Neuroradiology.

Sorin Aldea (S)

Neurosurgery, Rothschild Foundation Hospital.

Dorian Chauvet (D)

Neurosurgery, Rothschild Foundation Hospital.

Sophie Vo-Thanh (S)

Intensive Care Unit-Anesthesiology/Mobile Palliative Care Team.

Nathalie Versace (N)

Department of Neuroscience, Rothschild Foundation Hospital, Paris, France.

Léa Rohou (L)

Intensive Care Unit-Anesthesiology/Mobile Palliative Care Team.

Michel Piotin (M)

Interventional Neuroradiology.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH